Deal Library / Pharma BD Deal Intelligence

Pharma Deals of 2002

The Pharma Closeout tracks 23 deals, $111.9B in disclosed deal value, 18 with a post-close Outcome Score for the year 2002.

Median Critic Score: 75  ·  Median Outcome Score: 49

Best outcome: Roche Holding AG / Chugai Pharmaceutical Co. Ltd. (100)  ·  Weakest outcome: Schering AG / Collateral Therapeutics Inc. (9)

All 23 deals

• Roche Holding AG / Chugai Pharmaceutical Co. Ltd. — 2002 · $1.4B · Worked — the deal delivered on its rationale.
• Gilead Sciences Inc. / Triangle Pharmaceuticals Inc. — 2002 · $464M · Worked — the deal delivered on its rationale.
• Amgen Inc. / Immunex Corporation — 2002 · $16.0B · Worked — the deal delivered on its rationale.
• Novartis AG (Sandoz) / Lek Pharmaceuticals d.d. — 2002 · $876M · Worked — the deal delivered on its rationale.
• Bayer AG / BlueRock Therapeutics — 2002 · $600M · Worked — the deal delivered on its rationale.
• Novartis AG / Hexal AG — 2002 · $8.3B · Worked — the deal delivered on its rationale.
• Pfizer Inc. / Pharmacia Corporation — 2002 · $60.0B · Largely worked — most objectives met.
• Novartis AG / The Medicines Company — 2002 · $9.7B · Largely worked — most objectives met.
• Novartis AG / Chiron Corporation — 2002 · $5.4B · Mixed — partial payoff, real shortfalls.
• Bayer AG / Algeta ASA — 2002 · $2.9B · Mixed — partial payoff, real shortfalls.
• Teva Pharmaceutical Industries Ltd. / Honeywell Pharmaceutical Fine Chemicals S.r.l — 2002 · Underwhelmed — fell short of the thesis.
• Novartis AG / Selexys Pharmaceuticals — 2002 · $665M · Underwhelmed — fell short of the thesis.
• Baxter International Inc. / ESI Lederle (Wyeth generic injectable business) — 2002 · $316M · Underwhelmed — fell short of the thesis.
• MedImmune Inc. / Aviron Inc. — 2002 · $1.5B · Did not work — the deal failed to deliver.
• Schering AG / MAP Medical Technologies Oy — 2002 · Did not work — the deal failed to deliver.
• King Pharmaceuticals Inc. / Aventis Pharmaceuticals (Intal/Tilade/Synercid rights) — 2002 · $275M · Did not work — the deal failed to deliver.
• Roche Holding AG / Antisoma plc — 2002 · $500M · Did not work — the deal failed to deliver.
• Schering AG / Collateral Therapeutics Inc. — 2002 · $140M · Did not work — the deal failed to deliver.
• Abbott Laboratories / Biocompatibles International plc (cardiovascular stent business) — 2002 · $235M
• DSM N.V. / Roche Vitamins and Fine Chemicals Division — 2002 · $2.2B
• Johnson & Johnson / Tibotec-Virco NV — 2002 · $320M
• Teva Pharmaceutical Industries Ltd. / Bayer Classics (Bayer Pharma S.A. French generics division) — 2002 · $86M
• InterMune Inc. / Inhale Therapeutic Systems Inc. — 2002

← Deal Library  ·  Interactive search  ·  How we score deals